Mitoxantrone in progressive multiple sclerosis: when and how to treat?

This publication has 38 references indexed in Scilit:

• In vitro effects of dexrazoxane (Zinecard) and classical acute leukemia therapy: time to consider expanded clinical trials?
  Leukemia, 2001
• Anthracycline-induced cardiomyopathy
  Seminars in Oncology, 2001
• Cardiac Metabolism and Function in Patients with Multiple Sclerosis: A combined ³¹P-MR-Spectroscopy and MRI study
  RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 2001
• Cardiotoxicity of Chemotherapeutic Agents
  Drug Safety, 2000
• Dexrazoxane (ICRF-187)
  General Pharmacology: The Vascular System, 1999
• Die immunsuppressive Therapie der multiplen Sklerose mit Mitoxantron
  Fortschritte der Neurologie · Psychiatrie, 1993
• Suppression of demyelination by mitoxantrone
  International Journal of Immunopharmacology, 1991
• Suppression of acute and relapsing experimental allergic encephalomyelitis with mitoxantrone
  Clinical Immunology and Immunopathology, 1987
• Morphologic effects of mitoxantrone and a related anthracenedione on lymphoid tissues
  International Journal of Immunopharmacology, 1986
• Suppression of experimental allergic encephalomyelitis by mitoxantrone
  Clinical Immunology and Immunopathology, 1985